Sign in

CIK 0001281895

  • Non-accelerated filer
  • Smaller reporting company

ROCKET PHARMACEUTICALS, INC.

Sign in to watch
Ticker
RCKT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 646-440-9100
Business address
350 FIFTH AVENUE, SUITE 7530, NEW YORK, NY, 10118
Former names
INOTEK PHARMACEUTICALS CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$395,614
in 3 filings

Net −$395,614. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Wilson Martin −$384K General Counsel sold 19% of stake
  2. Chaudhuri Sarbani −$11K See Remarks sold 2% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-03-21 Militello John See Remarks Sale −2,490 $28.10 $70K 55,239
2024-02-29 Militello John See Remarks Option exercise +10,000 $12.55 $126K 31,517
2024-02-29 Militello John See Remarks Sale −10,000 $29.85 $298K 21,517
2024-02-29 Militello John See Remarks Option exercise · Stock Option (Right to Buy) −10,000 $12.55 $126K 0
2024-02-29 Wilson Martin General Counsel Sale −4,100 $29.33 $120K 18,680
2024-02-16 Wilson Martin General Counsel Sale −3,576 $29.84 $107K 6,136
2024-02-16 Wilson Martin General Counsel Grant or award +16,644 22,780
2024-02-16 Wilson Martin General Counsel Grant or award · Stock Option (Right to Buy) +49,091 49,091
2024-02-16 Patel Kinnari See Remarks Sale −7,132 $29.84 $213K 238,346
2024-02-16 Patel Kinnari See Remarks Grant or award +33,288 271,634
2024-02-16 Patel Kinnari See Remarks Grant or award · Stock Option (Right to Buy) +98,183 98,183
2024-02-16 Militello John See Remarks Sale −3,238 $29.84 $97K 13,195
2024-02-16 Militello John See Remarks Grant or award +8,322 21,517
2024-02-16 Militello John See Remarks Grant or award · Stock Option (Right to Buy) +24,545 24,545
2024-02-16 White Mark Andrew Chief Medical Officer Grant or award +11,096 87,758
2024-02-16 White Mark Andrew Chief Medical Officer Grant or award · Stock Option (Right to Buy) +32,727 32,727
2024-02-16 Shah Gaurav CEO Sale −20,272 $29.84 $605K 554,762
2024-02-16 Shah Gaurav CEO Grant or award +66,577 621,339
2024-02-16 Shah Gaurav CEO Grant or award · Stock Option (Right to Buy) +196,336 196,336
2024-02-14 Wilson Martin General Counsel Option exercise −9,712 9,712

Page 12 of 19 · 374 trades